Evidence map›Paper›PMID 36921295›Full record

ArticleRadiation research2023

Participation of ATM, SMG1, and DDX5 in a DNA Damage-Induced Alternative Splicing Pathway.

Jennifer J McCann, Donald E Fleenor, Jing Chen, Chun-Hsiang Lai, Thomas E Bass, Michael B Kastan

Abstract read
In one paragraph

Article in Radiation research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. ATM interaction with GRP94 modulates oncogenic receptor expression and signaling and microglial activation.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jennifer J McCannDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina 27710.
Donald E FleenorDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina 27710.
Jing ChenDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina 27710.
Chun-Hsiang LaiDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina 27710.
Thomas E BassDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina 27710.
Michael B KastanDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina 27710.

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI JOHN N. NORTON · 1985 to 2026
$174.8M
ROLE OF P53 IN THE CELLULAR RESPONSE TO DNA DAMAGER01ES005777 · NIEHS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KASTAN, MICHAEL B · 1992 to 2017
$2.3M
The Role of USP22 in Prostate Cancer Development and ProgressionK00CA212225 · NCI · DUKE UNIVERSITY · PI MCCANN, JENNIFER JONES · 2019 to 2022
$340k
NCI NIH HHS K00 CA212225NCI NIH HHS P30 CA014236NIEHS NIH HHS R01 ES005777
6 · The paper itself

Abstract

Altered cellular responses to DNA damage can contribute to cancer development, progression, and therapeutic resistance. Mutations in key DNA damage response factors occur across many cancer types, and the DNA damage-responsive gene, TP53, is frequently mutated in a high percentage of cancers. We recently reported that an alternative splicing pathway induced by DNA damage regulates alternative splicing of TP53 RNA and further modulates cellular stress responses. Through damage-induced inhibition of the SMG1 kinase, TP53 pre-mRNA is alternatively spliced to generate TP53b mRNA and p53b protein is required for optimal induction of cellular senescence after ionizing radiation-induced DNA damage. Herein, we confirmed and extended these observations by demonstrating that the ATM protein kinase is required for repression of SMG1 kinase activity after ionizing radiation. We found that the RNA helicase and splicing factor, DDX5, interacts with SMG1, is required for alternative splicing of TP53 pre-mRNA to TP53b and TP53c mRNAs after DNA damage, and contributes to radiation-induced cellular senescence. Interestingly, the role of SMG1 in alternative splicing of p53 appears to be distinguishable from its role in regulating nonsense-mediated RNA decay. Thus, ATM, SMG1, and DDX5 participate in a DNA damage-induced alternative splicing pathway that regulates TP53 splicing and modulates radiation-induced cellular senescence.

Indexed as

Alternative SplicingNeoplasmsAtaxia Telangiectasia Mutated ProteinsDEAD-box RNA HelicasesDNA DamageHumansProtein Serine-Threonine KinasesRNA PrecursorsAtaxia Telangiectasia Mutated ProteinsATM protein, humanDdx5 protein, humanDEAD-box RNA HelicasesProtein Serine-Threonine KinasesRNA PrecursorsSMG1 protein, human

Identifiers

PMID36921295
PMCPMC10162594

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.